advanced solid tumors cancer
Showing 1 - 11 of 11
Advanced Solid Tumors Cancer, Advanced Urothelial Carcinoma, Oral Drug Administration Trial in New York (FX-909)
Not yet recruiting
- Advanced Solid Tumors Cancer
- +3 more
-
New York, New YorkMemorial Slone Kettering Cancer Center
Jun 26, 2023
Advanced Solid Tumors Cancer Trial in Worldwide (Osimertinib, Nivolumab, Telisotuzumab vedotin)
Recruiting
- Advanced Solid Tumors Cancer
- Osimertinib
- +3 more
-
Scottsdale, Arizona
- +35 more
Jan 12, 2023
Advanced Solid Tumors Cancer, Non Small Cell Lung Cancer (NSCLC) Trial in Worldwide (ABBV-637, Docetaxel, Osimertinib)
Recruiting
- Advanced Solid Tumors Cancer
- Non Small Cell Lung Cancer (NSCLC)
- ABBV-637
- +2 more
-
Boston, Massachusetts
- +32 more
Dec 9, 2022
Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-151, Budigalimab)
Recruiting
- Advanced Solid Tumors Cancer
-
New Haven, Connecticut
- +29 more
Dec 5, 2022
Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-368, Tilsotolimod, Nab-paclitaxel)
Active, not recruiting
- Advanced Solid Tumors Cancer
- ABBV-368
- +3 more
-
Chicago, Illinois
- +25 more
Mar 9, 2022